Johnson Investment Counsel Inc Cytosorbents Corp Transaction History
Johnson Investment Counsel Inc
- $10.1 Billion
- Q3 2024
A detailed history of Johnson Investment Counsel Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 12,806 shares of CTSO stock, worth $12,806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,806
Previous 17,434
26.55%
Holding current value
$12,806
Previous $12,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CTSO
# of Institutions
54Shares Held
16.3MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$2.98 Million0.45% of portfolio
-
Skylands Capital, LLC2.78MShares$2.78 Million0.38% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$2.09 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.95 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.78 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $43.6M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...